CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM

CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM

Circulating tumor cells (CTCs) are promising diagnostic and prognostic tools for clinical use. In several cancers, including colorectal and breast, the CTC load has been associated with a therapeutic response as well as progression-free and overall survival. However, counting and isolating CTCs rema...

Full description

Bibliographic Details
Main Authors: Guillaume Belthier, Zeinab Homayed, Fanny Grillet, Christophe Duperray, Julie Vendrell, Ilona Krol, Sophie Bravo, Jean-Christophe Boyer, Olivia Villeronce, Jihane Vitre-Boubaker, Diana Heaug-Wane, Françoise Macari-Fine, Jai Smith, Matthieu Merlot, Gérald Lossaint, Thibault Mazard, Fabienne Portales, Jérôme Solassol, Marc Ychou, Nicola Aceto, Emilie Mamessier, François Bertucci, Jean Marc Pascussi, Emmanuelle Samalin, Frédéric Hollande, Julie Pannequin
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Cancers
Subjects:
circulating tumor cells
colorectal cancer
breast cancer
biomarker
patient blood samples
EMT
Online Access:https://www.mdpi.com/2072-6694/13/19/4966

Internet

https://www.mdpi.com/2072-6694/13/19/4966

Similar Items